< Back to previous page
Patent
Androgen receptor splice variants and androgen deprivation therapy
The present invention provides androgen receptor splice variants that are associated with resistance to androgen deprivation therapy, such as treatment with abiraterone acetate or enzalutamide. The present invention is especially useful in the field of oncology, including prostate cancer diagnosis, characterization, classification and treatment.
Patent Publication Number: EP3464623
Year filing: 2021
Year approval: 2021
Year publication: 2021
Status: Assigned
URI: link to Espacenet
Technology domains: Biotechnology
Validated for IOF-key: Yes
Attributed to: Associatie Universiteit & Hogescholen Antwerpen